Fake cough syrup manufacturing unit busted
Link to article when available or URL to publication: http://www.business-standard.com/generalnews/news/fake-cough-syrup-manufacturing-unit-busted/102608/
A unit which produced spurious cough syrup has been raided in Niwari area of the district and over500 bottles of the fake substance seized.According to Niwari SHO Shahnazar Ahmad, 550 bottles of thefake syrup were recovered along with colour, equipment and raw material used in the manufacture ofthe drug, during the raid that was carried out on Saturday night.The person allegedly behind the dodgyoperation, one Sachin, a resident of Delhi, has been apprehended by police.
Crooks use ‘defence’ tag to supply illicit liquor
Link to article when available or URL to publication: http://indiatoday.intoday.in/story/fake-liquor-brands-cheap-duplicate-labels-of-alcohol-seized/1/240319.html
Next time, if you see a liquor bottle bearing the stamp of ‘For Sale to Defence Personnel Only’, don’tblindly trust its quality, for it could be illicit liquor with fake labels. Excise officials have seized duplicatelabels of Indian Manufactured Foreign Liquor (IMFL) meant for defence personnel only. As many as 20boxes of liquor bottles were also recovered from the accused. It is suspected that such labels mighthave been used for selling Haryana-made liquor or any illicit alcohol in the national Capital. Exciseintelligence officials, for the last few months, have been cracking down harder on those who smuggleliquor from other places to the Capital. The smuggled liquor has not only caused revenue loss to theDelhi government but also raised alarm over the quality of alcohol served in the city. In the massivecrackdown, the officials have seized 82,589 bottles of IMFL and 2,656 bottles of foreign liquor this yeartill December 25. When compared to the last year’s data, the recovery in case of IMFL was more thanthree times this year while in case of foreign liquor it was four times. However, the seizure of fake labelsof IMFL meant for defence personnel on December 17 was an eye-opener. The officials also recovered20 boxes of liquor from the car of Anil Sharma. Sharma, who was reportedly staying in high securitySouth Avenue locality, was caught at Mother Teresa Crescent road in Chanakyapuri. After the seizure,the case was referred to the local police for investigation and an FIR was registered. A preliminaryinquiry revealed that the accused was coming from Haryana, and liquor was meant for delivery inthe Capital.A police official said that samples of liquor of all the brands had been sent for qualityexamination and the reports were awaited. A senior excise department official said it was alarming asthese labels could be used for selling illicit liquor. “How could one verify if he sells inferior quality ofliquor by pasting these labels (on bottles)? People can easily be cheated under the impression that theliquor is of good quality as it is for defence personnel,” said the official. Official sources said it is commonpractice to procure costly liquor from outside and serve it in parties in the Capital to evade taxes.
2.3L fake UIDs found in Andhra Pradesh
Andhra Pradesh has earned the dubious distinction of having issued the highest number of bogus Aadhaar numbers in the country. Of the 3.84 lakh fake numbers nationwide, 2.3 lakh were from the state.Unique Identification Authority of India officials have cancelled the fake numbers which were issued without taking biometrics such as fingerprints or iris scans.Sources said the fake numbers were generated by enrolment agencies who misused the “biometric-exemption clause”. While the clause is meant for rare cases where it’s difficult to take fingerprints or iris scans (like for those suffering from leprosy or are blind), some agencies enrolled those who did not fall under this category.Even under the exemption clause, the agencies are supposed to procure photographs and demographic information of those enrolled, but it seems the agencies provided fake information to earn extra money. The government pays around ‘50 for each Aadhaar number generated.“Majority of the bogus Aadhaar numbers were issued in Nellore, Ongole and some areas of Hy-derabad district… We have identified about six enrolment agencies involved in the fraud and have blacklisted them,” said M.V.S. Rami Reddy, deputy director-general, UIDAI, AP.Officials suspected foul play after nearly 50,000 cards were returned undelivered.Other states where fake Aadhaar numbers were issued were Maharashtra (39,000), Jharkhand (33,000), TN (19,000), Odisha (18,000), Delhi (14,000) and UP (8,000).
Lear MoreCounterfeit medicine proving deadly in Africa
Parts of Africa are seeing a dangerous rise in the amount of counterfeit medication – for diseases such as malaria – coming largely from Asia.According toThe Guardian, a combination of lax regulatory oversight in China and sub-par border security in Africa has led to a wave of at-best ineffective medicines making their way to malaria patients across the continent.”What we are told is this, if someone wants to counterfeit a drug, they just take the package to China and they can make it in thousands,” David Nahamya – chief drug inspector for the Ugandan national drug authority – told The Guardian. “You have seen how they make it there. They can copy anything.”A recent story by The Guardian showed that nearly a third of all malaria drugs making their ways to Uganda and Tanzania are illicit, which adds an extra layer of intrigue to China’s burgeoning trade market with African nations.The Atlanta Black Starpointed out that even China’s “CCTV” has made its way to the neighboring land mass, along with the newspaper The China Daily.For their part,China has refutedthe claims made by The Guardian, pointing out their contributions to Africa’s fight against malaria.
http://www.digitaljournal.com/article/340156
Lear MoreCounterfeit Cancer Medicines Multiply
The fake Avastin that surfaced in the U.S. this year grabbed headlines, but it was just one example of a growing problem in the pharmaceutical world: the rise of counterfeit cancer drugs.Fake versions of costly cancer medicines have appeared in increasing numbers in Asia and the Middle East in recent years and occasionally in Europe and the U.S. In 2011, cancer drugs ranked eighth among the top 10 types of drugs targeted by counterfeiters, according to the Pharmaceutical Security Institute, an industry-funded group; five years ago, they weren’t on the list at all.Authorities have seized some of the fakes in warehouses or shipping containers before they reached patients. But other counterfeits have turned up in pharmacies and hospitals, in one case injuring 80 patients in Shanghai.Counterfeiters are targeting cancer drugs because of the big profits to be made. While pills such as Viagra, long a favorite of the counterfeit trade, cost about $15 to $20 a tablet, a 400-milligram vial of the injectable drug Avastin costs about $2,400.Many of the fake cancer drugs seized in recent years were produced in China, where weak regulation and rapid industrialization have helped counterfeiting flourish. Law-enforcement authorities investigating the origins of the counterfeit Avastin found in the U.S. this year have considered China as a possible source.The fake Avastin traveled through Turkey and the U.K. before reaching the U.S. market. The U.S. Food and Drug Administration later warned dozens of doctors that they might have purchased the fakes from distributors owned by Canada Drugs, a Winnipeg Internet pharmacy company. The fakes contained starch, salt, cleaning solvents and other chemicals and none of the genuine drug’s active ingredient, bevacizumab, according toRoche HoldingAG,ROG.VX-0.92%Avastin’s manufacturer.The FDA declined to comment on the investigation of the matter, which it is leading, citing a policy against discussing continuing probes. Roche declined to comment on the possible origins of the counterfeits.Canada Drugs executives didn’t respond to a request for comment. The company’s employees previously acknowledged in interviews that they shipped the fake drug but said they didn’t know it was counterfeit.The fake Avastin found in the U.S. is just a small part of the global trafficking in counterfeit cancer drugs. A police raid in the Chinese city of Guangzhou last year netted 23 million tablets of a variety of counterfeit drugs, including bogus copies of the generic breast-cancer drug tamoxifen, according to Chinese law-enforcement documents.In March 2010, customs officers in Malta seized a cargo of counterfeit Gleevec, NovartisAG’sNOVN.VX-0.43%leukemia drug, according to Anthony Busuttil, director of enforcement for Maltese customs. He declined to comment on where the fakes came from or where they were being shipped.”There’s been an increase I’d say in the last five to six years” in the counterfeiting of cancer drugs, said Andrew Jackson, head of global security at Novartis. “The industry is obviously looking at this more rigorously than ever before….I suspect that the bad guys have clocked onto the huge profits that can be made.”The most serious case yet to hit Europe involved fakes of AstraZeneca AZN.LN-0.46% PLC’s breast-cancer drug Casodex, which reached U.K. pharmacies in 2007. The counterfeits were made in China, and sent through Hong Kong, Singapore and Belgium before reaching the U.K., where a little-known wholesaler called Consolidated Medical Supplies repackaged the tablets in French packaging and sold them to unsuspecting wholesalers and pharmacies, according to the U.K.’s Medicines and Healthcare products Regulatory Agency, or MHRA.The head of Consolidated Medical Supplies, a Briton named Peter Gillespie, was sentenced to eight years in prison in 2011 for counterfeiting-related offenses including conspiracy to defraud.The U.K. tried to recall the bogus cancer drugs, along with fake schizophrenia and heart-disease medications also sold by Mr. Gillespie, but was unable to account for 700,000 doses that already had reached pharmacies and patients.A Chinese national named Kevin Xu was responsible for selling the counterfeits, according to the MHRA. Mr. Xu was later caught attempting to sell the same types of counterfeits to undercover federal agents in Houston and in 2009 was imprisoned in the U.S. for distributing counterfeit and misbranded pharmaceuticals.Simeon Wilson, global security director at AstraZeneca, said the company now has four staffers in China dedicated to hunting down counterfeit factories. The investigators assemble evidence of alleged wrongdoing and give it to Chinese police for enforcement action.”When we do it, and do it properly, the Chinese authorities have never turned us down,” he said.Still, in the southern manufacturing city of Guangzhou alone, where many of the Chinese-made fakes originate, there are “thousands and thousands” of counterfeiting companies operating, he said. Some making counterfeit medications are licensed as chemical manufacturers, which means they aren’t subject to regulation or inspections by China’s State Food and Drug Administration.The SFDA and China’s Ministry of Public Security didn’t respond to requests for comment for this article.Fake cancer drugs coming out of China have been found to contain everything from harmless placebo ingredients to potentially harmful material to some of the active ingredients in the genuine drugs, said Novartis’s Mr. Jackson. The counterfeit Casodex that reached the U.K. contained 50% to 80% of the active ingredient in the legitimate product, along with “unknown impurities,” the MHRA said.The regulator didn’t respond to questions about whether the fakes had harmed any patients.Chinese patients have been particularly vulnerable to the counterfeits. In 2010, 80 patients taking part in a clinical trial in Shanghai developed acute inflammation of the eye after doctors inadvertently gave them counterfeit Avastin, according to a 2011 report in the New England Journal of Medicine.According to the Shanghai government, 17 of the patients required surgery to fix the problem. The fake Avastin vials contained saline that was contaminated with bacterial endotoxin, the Shanghai government said.Last year, 11 people were convicted of making and selling the counterfeits, including Wu Guosong, a counterfeiter from Heilongjiang province identified by authorities as the group’s ringleader. He got a prison sentence of two years and 10 months.
http://online.wsj.com/article/SB10001424127887323320404578211492452353034.html
Lear MoreRegion rolls out sim card switch-off
The crackdown on fake phones and unregistered subscribers in East Africa is expected to gain fresh impetus in 2013 as countries move to stop crime and stem the rising imports of counterfeit devices.Kenya is set to switch off users of unregistered sim cards this week in a move aimed at stopping criminals who use mobile phones to threaten and extort money from the public.The Communications Commission of Kenya has given mobile subscribers using unregistered sim cards up to December 31 to register or be switched off from all four local networks. Other countries in the East African Community are following in Kenya’s footsteps and have independently launched similar projects with the aim of beefing up security in the use of mobile phones.In Uganda, the communications regulator has set March 1, 2013, as the new deadline for mobile users to register their sim cards and July 1 for the switch off of counterfeit phones. Tanzania also plans to rid the country of counterfeit phones.The Tanzania Communications Regulatory Authority says it is planning to run a campaign in 2013 to educate the public on the need to have genuine phones, before disconnecting users.The Rwanda Utilities Regulatory Authority (Rura) says it also has plans to switch off fake phones.The regulator says the counterfeit phones switch off is an initiative that was agreed upon within the East African Communications Organisation.On their own, mobile operators have rolled out various campaigns over the past few months seeking to sensitise their customers on the need to have their lines registered.“We are acting on the regulator’s instructions because we also understand the motive behind the move. We hope to have all our subscribers registered by the deadline but we will unfortunately switch off all sim cards that will not have been registered,” said yuMobile chief executive Madhur Taneja.Safaricom and Telkom Orange have also confirmed that they will comply with the regulator’s instructions.
Lear MoreThree more held in fake memory card racket
Three more persons were arrested by the Kurla Government Railway Police (GRP) in connection with the fake phone memory card racket. The trio, all dealers of fake cards, were picked up from Thane station on Thursday. The accused used a mixture of molten tar and bottle caps and wrapped it in plastic to resemble memory cards, peddling them on foot overbridges and outside railway stations.”We have arrested Shahbaz Khan, 19, Imran Khan 19 and Mohammed Afsar Ali Khan, 19 on Thursday. Around 1000 fake memory cards and 10 fake pen drives were seized from them. A railway court has remanded the trio to police custody till December 29,” a GRP official said. The total number of arrests in the case has now gone up to six the GRP had arrested three persons on Tuesday and seized 600 memory cards from them.During investigation, the police found that original memory cards were sold in the market for Rs 400, while the accused peddled the fake memory cards for as low as Rs 20, attracting a large number of customers. The cost involved in manufacturing fake memory cards is only Rs 3.50. The accused would operate at one location only for an hour.
Lear More![](https://www.ficcicascade.in/wp-content/uploads/2018/08/Malaria-and-antiretrovira-010.jpg)
China rejects claims of producing fake medicine for Africa
China has denied allegations that it has been exporting huge amounts of counterfeit medication to Africa, threatening public health in east Africa, five days after the Guardian published a front page exposé on the phenomenon.The official Xinhua news agency said a foreign ministry spokeswoman rejected the accusation, but “called on foreign traders to procure medicines from legitimate companies through standardised channels”.”Spokeswoman Hua Chunying said at a daily press briefing that the accusations are unfounded, noting that co-operation between the Chinese government and African countries has played an important role in improving the healthcare environment for people in Africa,” Xinhua reported on Thursday night.The Guardian article cited experts and NGO reports as saying that up to a third of anti-malarial drugs in Uganda and Tanzania may be fake or substandard, and that the majority of them are manufactured in China and India. The drugs look identical to real ones, and can only be distinguished with lab testing. Aside from malaria drugs, analysis of antibiotics and contraceptives have also turned up fakes. “Some pills contain no active ingredients, some are partial strength and some the wrong formulation entirely,” said the article.The fake medications have led to deaths, prolonged illness and increased drug resistance in areas of east Africa, the article said.A Chinese foreign ministry official refused to specify which parts of the Guardian article the ministry disputed. She said that the repudiations were aimed at the question of counterfeit drug exports, not the article specifically. Counterfeit drugs are an endemic and long-running issue in China. According to official statements, Chinese police seized £113m worth of fake pharmaceuticals this July alone and £19m worth last November. Many ingredients were found to be harmful or toxic.According to Xinhua, the foreign ministry spokeswoman “stressed that China always attaches great importance to drug safety and resolutely cracks down on the manufacture and sale of counterfeit drugs” and defended Beijing’s record of providing healthcare aid to African countries.
http://www.guardian.co.uk/world/2012/dec/28/china-rejects-fake-medicine-africa
Lear More![](https://www.ficcicascade.in/wp-content/uploads/2018/08/Unveiling-of-the-New-Cyber-Safety-Educational-Poster.jpg)
63% of counterfeits infected with malware, claims Microsoft
MICROSOFT Corp has unveiled the results of a South-East Asia internal computer security study which found that 63% of counterfeit software DVDs and laptop computers with illegal copies of Windows and other software had high-risk malware infections and viruses.A staggering 85% of the sampled DVDs and 49% of sampled computers were found to contain malware, the company said in a statement.The analysis was conducted by Microsoft’s Security Forensics team on albeit only 118 samples purchased from resellers in Indonesia, Malaysia, the Philippines, Thailand, and Vietnam.In total, this preliminary test sample found nearly 2,000 instances of malware – 403 of them unique – including highly dangerous backdoors, hijackers, droppers, bots, crackers, password stealers, and trojans.The research further revealed that in 77% of the computers examined, Windows Update had been disabled or re-routed to third-party services. With Windows Update disabled, computer systems bypass genuine software checks and are also denied access to critical security updates, leaving them defenseless against malicious cyber-attacks, virus infections, and hacking.More interestingly is a new trend that was discovered during the course of the study – 44% of the sampled, seemingly new laptop computers have had the original hard drives swapped with malware-infected, recycled drives installed with pirated software.
Cybercriminals use malware for a range of invasive activities generating illegal profit – from stealing consumers’ banking and credit card information, to spamming their e-mail and social media contacts with fraudulent requests for charitable donations or bogus offers (e.g., for counterfeit prescription drugs).Increasingly, these activities are conducted by or at the direction of organized, for-profit criminal enterprises.For businesses, the risks associated with using malware-infected, pirated software include low IT productivity, critical system failures and disruptions of service, and theft of confidential company data leading to severe financial loss and reputational harm.
“This study clearly shows that using counterfeit software is a dangerous proposition,” said Dr Dzahar Mansor, national technology officer at Microsoft Malaysia.
“Pirated software is a breeding ground for cybercrime, and the cost of using it is potentially much higher than the price of buying genuine in the first place,” he added.
According to the 2012 Norton Cybercrime Report, the global consumer cost of cybercrime is US$100 billion annually, with an average per-victim impact of US$197.
“Using a PC with counterfeit software is like moving into a high-crime neighborhood and leaving your doors open – it’s incredibly risky,” said Zahri Hj. Yunos(pic above, left), acting chief executive officer of CyberSecurity Malaysia (CSM), an agency under Malaysia’s Ministry of Science, Technology and Innovation.
“People with counterfeit software have no guarantee that their sensitive data, activities and communications will be safe from cybercriminals that intend to do harm. As the results of this study show, the danger of counterfeit is real and consumers should insist on genuine software when purchasing a new PC,” he added.
Microsoft advises consumers to take the following steps to avoid the inadvertent purchase of counterfeit software:
- Always ask for genuine software.
- Buy from a trusted reseller and avoid deals that seem “too good to be true”.
- Ensure all software purchases come in their original packaging.
- When buying a PC with Windows, look for the genuine label and Certificate of Authenticity that Microsoft requires be affixed to all PCs on which Windows is pre-installed. As a further check after purchase, log on tohttp://www.howtotell.com/to confirm the label is authentic.
Customers who suspect they’ve received pirated or counterfeit software are encouraged to report it atwww.microsoft.com/piracy. Since 2007, the company has received more than 10,000 piracy reports from within South-East Asia – many from people who bought a name-brand PC, paying more money to get “the real thing,” but ending up with far greater risk and liability at the hands of counterfeiters.
Microsoft said it is currently expanding its research in South-East Asia to include an even larger sample of PCs and DVDs containing pirated software, and expects to publish the full study results and analysis during the first quarter of 2013.
Lear More![](https://www.ficcicascade.in/wp-content/uploads/2018/08/unknown_6-34559684.jpg)
Swiss technology battles fake drugs
Counterfeit drugs have become one of the main health problems in developing countries. A device developed by three Swiss universities that identifies fake drugs could save the lives of hundreds of thousands of people worldwide.“The phenomenon of fake drugs reached catastrophic dimensions a long time ago for the inhabitants of the world’s poorest regions,” said Claude Rohrbasser, retired head of industrial technology at the College of Engineering and Architecture of Fribourg.“So several years ago we said to ourselves that with our knowledge and technological possibilities, we could do something to help these people.”The Fribourg institute joined forces with the Geneva University Hospitals and Geneva-Lausanne School of Pharmacy to develop a low-cost system that identifies whether a drug is real or fake in just a few minutes.The prototype of the ECB (budget capillary electrophoresis) was unveiled in 2008.“The devices on the market cost at least SFr100,000 ($110,000). The ECB is only SFr10,000. For this amount we can find sponsors, whereas for SFr100,000 it would be pretty tricky,” said Rohrbasser, now president of Pharmelp, an association created by the initiative’s promoters to make the ECB available in developing countries.
Simple and effective
Despite its complicated name, the ECB represents probably the easiest – and at the same time most efficient – solution yet developed to detect and measure organic compounds, as well as drugs, proteins and amino acids.The ECB enables the analysis of 80 per cent of the 200 core medicines identified by the World Health Organization (WHO).“Our aim was to develop an instrument that was extremely robust and as simple as possible from a functional point of view. This was to reduce the problem of a lack of spare parts and facilitate the training of staff in the countries where it would be used,” said Serge Rudaz, associate professor at Geneva University’s School of Pharmaceutical Sciences.Another advantage of the ECB is that it uses a minimum dose of solvent – barely a millionth of a litre – per analysis.“In recent years, some solvents necessary for this analysis have gone off the market or have undergone major price increases, to the point of becoming unaffordable for health operators in developing countries,” Rudaz said.
· Counterfeited medicines
According to the World Health Organization (WHO), less than 20 per cent of counterfeited medicines are comparable to the original product.In more than 80 per cent of cases the counterfeited medicines do not correspond to the information in the package inserts, which can severely endanger patients’ health.Thirty-two per cent of seriously altered mediciations don’t contain any of the active ingredient the medicine is supposed to contain, in 21 per cent the active ingredient differs from the original substance, in 20 per cent there is too little of the active ingredient, and in 8 per cent there are impurities in the drug.
· Electrical pulse
The analysis takes just 20 minutes on average. First of all the drug is solubilised with water. A small quantity of the substance is set in motion by an electrical pulse (hence the name electrophoresis), then moves along a tube thinner than a hair (hence capillary).
Using ultraviolet rays, the device measures the duration of the drug’s journey, which is recorded on a normal laptop computer.
“The ECB can’t identify the medicinal composition – it verifies whether this duration corresponds to that of the original product. Each drug has its own charge and thus moves at a different speed,” Rudaz explained.To date, the institutes have produced around ten ECB devices. The first three are already being used by the national health laboratory in Bamako, Mali, by Dakar University in Senegal and by the health authorities in Phnom Penh, Cambodia.Other projects are planned in Congo, Ghana and the Ivory Coast.
· Kidney problems
In these countries, a high percentage of drugs in circulation are counterfeit. In the majority of cases they are completely or partially lacking in the active ingredient listed in the packaging.According to the WHO, these fake drugs are responsible for the deaths of hundreds of thousands of people a year around the world, including 200,000 people with malaria.What’s more, for several years increasing numbers of impure drugs have been circulating, coming mostly from Asia.“Over the long term, these attack the kidneys – we’re noticing more and more patients in poor countries who need dialysis. The consequences are terrible, given the meagre means available,” Rohrbasser said.“Two years ago I visited the dialysis centre of the hospital in Bamako. There were ten or so patients lined up on beds. The head doctor told me they would die within a week because there weren’t any more filters for dialysis. This is another aspect of the problem of fake drugs.”
· Official challenges
The trafficking of these drugs is tied to the inadequacy of health networks in poorer countries, above all outside the main inhabited centres. Many people get the drugs from travelling salesmen, who move from village to village.“You’ve also got to bear in mind the tight financial circumstances. In many African countries people will normally buy only one or two pills at a time. And often they’ll do this at market, where prices are lower than in pharmacies and hospitals,” Rohrbasser said.But the official sales channels aren’t without problems either. Political instability and war – as is the case currently in Mali – often obstruct the already precarious control measures for the drugs.“But our aim is not to do the job of the police or customs – rather it’s to make available to the authorities, to hospitals and to universities an instrument which can identify fake products,” he said.This pragmatism is shared by Serge Rudaz. “There’s no way we can solve the problem of counterfeiting in the countries with which we’re working. But our presence bears witness to the interest of our universities and of Switzerland in tackling the serious problems [these countries] face.”
http://www.swissinfo.ch/eng/science_technology/Swiss_technology_battles_fake_drugs.html?cid=34595272
Lear More